Literature DB >> 31605763

Timing and predictors of repeat epinephrine administration among children hospitalized for anaphylaxis.

Timothy E Dribin1, Kenneth A Michelson2, Michael C Monuteaux2, David Schnadower3, Mark I Neuman2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31605763     DOI： 10.1016/j.jaip.2019.09.028

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  4 in total

1.  Anaphylaxis knowledge gaps and future research priorities: A consensus report.

Authors:  Timothy E Dribin; David Schnadower; Julie Wang; Carlos A Camargo; Kenneth A Michelson; Marcus Shaker; Susan A Rudders; David Vyles; David B K Golden; Jonathan M Spergel; Ronna L Campbell; Mark I Neuman; Peter S Capucilli; Michael Pistiner; Mariana Castells; Juhee Lee; David C Brousseau; Lynda C Schneider; Amal H Assa'ad; Kimberly A Risma; Rakesh D Mistry; Dianne E Campbell; Margitta Worm; Paul J Turner; John K Witry; Yin Zhang; Brad Sobolewski; Hugh A Sampson
Journal:  J Allergy Clin Immunol       Date:  2021-08-12       Impact factor: 10.793

2.  Safely Reducing Hospitalizations for Anaphylaxis in Children Through an Evidence-Based Guideline.

Authors:  Lukas K Gaffney; John Porter; Megan Gerling; Lynda C Schneider; Anne M Stack; Dhara Shah; Kenneth A Michelson
Journal:  Pediatrics       Date:  2022-02-01       Impact factor: 9.703

3.  PEMCRC anaphylaxis study protocol: a multicentre cohort study to derive and validate clinical decision models for the emergency department management of children with anaphylaxis.

Authors:  Timothy E Dribin; Kenneth A Michelson; David Vyles; Mark I Neuman; David C Brousseau; Rakesh D Mistry; Peter S Dayan; Nanhua Zhang; Shiv Viswanathan; John Witry; Stephanie Boyd; David Schnadower
Journal:  BMJ Open       Date:  2021-01-05       Impact factor: 2.692

Review 4.  The 2020 update on anaphylaxis in paediatric population.

Authors:  Izabela Tarczoń; Ewa Cichocka-Jarosz; Anna Knapp; Przemko Kwinta
Journal:  Postepy Dermatol Alergol       Date:  2021-02-06       Impact factor: 1.837
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.